Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/1HM stock hub

FRA/1HM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/1HMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/1HMFRA/1HM

—

Loading chart…

In the news

Latest news · FRA/1HM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-24

P25 n/aP50 n/aP75 n/a

ROIC-6.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/1HM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

USD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	624
Employees Change	-90%
Employees Change Percent	-12.69
Enterprise value	EUR 1.9B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	In Vitro and In Vivo Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.9B
Price	EUR 11.55
Price currency	EUR
Rev Per Employee	410,587.33x
Sic	2835
Symbol	fra/1HM
Website	https://www.adaptivebiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.29%
EV Earnings	-43.16x
EV/FCF	-72.61x
EV/Sales	7.41x
FCF yield	-1.36%
P/B ratio	9.66x
P/S ratio	7.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-15.82%
EBITDA Margin	-10.08%
Gross margin	43.71%
Gross Profit	EUR 112M
Gross Profit Growth	497.6%
Gross Profit Growth Q	153.47%
Net Income	EUR -43.1M
Pretax Margin	-16.8%
Profit Margin	-16.82%
Profit Per Employee	EUR -69,050
ROA	-5.74
Roa5y	-13.29
ROCE	-11.15
ROE	-23.95
Roe5y	-43.39
ROIC	-6.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	62.75%
Cagr3y	29.16%
Cagr5y	-16.52%
Revenue Growth	55.87x
Revenue Growth Q	35.15x
Revenue Growth3 Y	17.02x
Revenue Growth5 Y	20.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.58
Assets	EUR 438.8M
Cash	EUR 189.4M
Current Assets	EUR 247.4M
Current Liabilities	EUR 73.8M
Debt	EUR 180.6M
Debt Equity	EUR 0.93
Debt FCF	EUR -7.05
Equity	EUR 194.5M
Interest Coverage	-3.97
Liabilities	EUR 244.3M
Long Term Assets	EUR 191.4M
Long Term Liabilities	EUR 170.5M
Net Cash	EUR 25.2M
Net Cash By Market Cap	EUR 1.34
Net Cash Growth	135.77%
Net Debt Equity	EUR -0.13
Tangible Book Value	EUR 83.3M
Tangible Book Value Per Share	EUR 0.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.35
Inventory Turnover	16.72
Net Working Capital	EUR 675,627
Quick ratio	3.08
Working Capital	EUR 177.6M
Working Capital Turnover	EUR 1.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	62.69%
200-day SMA	12.68
3Y total return	115.48%
50-day SMA	12.08
50-day SMA vs 200-day SMA	50under200
5Y total return	-59.46%
All Time High	59.5
All Time High Change	-79.02%
All Time High Date	2021-01-19
All Time Low	2.15
All Time Low Change	481.24%
All Time Low Date	2024-04-19
ATR	0.4
Ch YTD	-10.31
High	12.34
High52	17.71
High52 Date	2025-11-25
High52ch	-34.79%
Low	11.55
Low52	7.68
Low52 Date	2025-05-23
Low52ch	50.37%
Ma50ch	3.37%
Price vs 200-day SMA	-1.51%
RSI	45.6
RSI Monthly	53.86
RSI Weekly	45.92
Sharpe ratio	0.79x
Sortino ratio	1.39
Total Return	-3.62%
Tr YTD	-10.31
Tr1m	3.78%
Tr1w	4.35%
Tr3m	-6.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -40.5M
Operating margin	-15.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	125,373,598%
Shares Insiders	2.92%
Shares Institutions	79.01%
Shares Qo Q	1.56%
Shares Yo Y	3.62%
Short Ratio	4.45

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -70.1M
Average Volume	20.25x
Bv Per Share	1.17
CAPEX	EUR -2.2M
Ch1m	3.78
Ch1w	4.35
Ch1y	62.69
Ch3m	-6.13
Ch3y	115.5
Ch5y	-59.46
Ch6m	-6.2
Change	-4.78%
Change From Open	-6.44
Close	12.13
Days Gap	1.77
Depreciation Amortization	14,363,628.3
Dollar Volume	2,482.2
Earnings Date	2026-05-05
EBIT	EUR -40.5M
EBITDA	EUR -25.8M
EPS	EUR -0.28
F Score	5
FCF	EUR -25.6M
FCF EV Yield	-1.38x
Financing CF	28,145,620
Fiscal Year End	December
Founded	2,009
Goodwill	100,883,735.1
Investing CF	18,664,296
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Ma150	13.4
Ma150ch	-6.79%
Ma20	11.88
Ma20ch	5.06%
Net CF	23,358,991
Open	12.34
Position In Range	0
Ppne	60,223,957.2
Price Date	2026-05-08
Ptbv Ratio	22.54
Relative Volume	10.62x
Revenue	256,206,491x
SBC By Revenue	17.35x
Share Based Comp	44,461,267
Tr6m	-6.2%
Volume	215
Z Score	1.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/1HM pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/1HM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/1HM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+79.0%

Share of float held by funds and institutions

Insider ownership

+2.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/1HM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.6

Neutral momentum band

Price vs 200-day MA

-1.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.79

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/1HM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/1HM stock rating?

fra/1HM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/1HM analysis?

The full report lives at /stocks/fra/1HM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/1HM?

The latest report frames fra/1HM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/1HM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.